In a twist worthy of a plotline in a cannabis-themed thriller, a lesser-known cannabinoid called CBG has left scientists pleasantly surprised—and perhaps a little bewildered.
Marijuana use has stayed pretty chill between 2022 and 2023, according to a new federal report by the Substance Abuse and Mental Health Services Administration (SAMHSA).
Hold onto your green hats, folks! The cannabis industry in the U.S. is growing faster than a weed in a rainforest. According to a report by Vangst and Whitney Economics, the industry’s workforce has blossomed to over 440,000 green-thumbed employees.
Hold onto your sushi rolls, folks! Japan’s cannabis market is blowing up like a well-timed firework display.
Hold onto your hats, folks, because the green wave is about to make some serious cash – to the tune of $31 billion, according to the pot prophets at Whitney Economics. Yes, you heard that right – the cannabis industry is set to rake in more dough than a bakery on 4/20.
The German Bundesrat just greenlit a plan to make weed as common as pretzels in a beer garden! Yep, you heard that right – the land of sausages and schnitzels is loosening up with a limited cannabis legalization plan. But fear not, lederhosen lovers, it’s not a free-for-all Oktoberfest of pot just yet.
Morocco has recently marked a significant milestone by entering the realm of regulated cannabis cultivation, concluding 2023 with its inaugural legal harvest.
New York Governor Kathy Hochul made an announcement on Monday, indicating her administration’s commitment to evaluating the state’s implementation of legalized recreational marijuana. She stressed the importance of this assessment to ensure the prosperity of the regulated cannabis market.
Governor Kathy Hochul of New York has urged major social media companies, including Google and Yelp, to cease displaying listings for unlicensed cannabis retailers. At a press conference, Hochul, accompanied by licensed dispensary owners facing challenges from unlicensed competitors, emphasized the need to address this issue.
A scarcity of stimulant-based medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in the U.K. has triggered a surge in patients turning to medical cannabis as an alternative for relief. The rise in individuals seeking medical cannabis highlights the growing demand for alternative treatments amidst the medication shortage.
